Literature DB >> 5547729

Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse.

H D Christensen, R I Freudenthal, J T Gidley, R Rosenfeld, G Boegli, L Testino, D R Brine, C G Pitt, M E Wall.   

Abstract

The 11-hydroxy metabolites of Delta(8).- and Delta(9)-tetrahydrocannabinol are more active than the parent compounds when administered to mice by either the intravenous or intracerebral route. Both Delta(8)- and Delta(9)-tetrahydrocannabinol are rapidly and extensively metabolized by the liver and not by the brain. The hypothesis that the 11-hydroxy metabolites may be the active form of tetrahydrocannabinol is discussed

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5547729     DOI: 10.1126/science.172.3979.165

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  23 in total

1.  The effect of cannabinol delta1-tetrahydro-cannabinol clearance from the blood.

Authors:  N K McCallum
Journal:  Experientia       Date:  1975-08-15

2.  Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats.

Authors:  Laurie A Manwell; Paul E Mallet
Journal:  Psychopharmacology (Berl)       Date:  2014-11-15       Impact factor: 4.530

3.  Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones.

Authors:  Alex Straiker; Jim Wager-Miller; Jacqueline Hutchens; Ken Mackie
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 4.  Cannabis use during pregnancy: Pharmacokinetics and effects on child development.

Authors:  Kimberly S Grant; Rebekah Petroff; Nina Isoherranen; Nephi Stella; Thomas M Burbacher
Journal:  Pharmacol Ther       Date:  2017-08-25       Impact factor: 12.310

5.  A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man.

Authors:  M Perez-Reyes; M C Timmons; M A Lipton; H D Christensen; K H Davis; M E Wall
Journal:  Experientia       Date:  1973-08-15

6.  delta9-Tetrahydrocannabinol and the extrapyramidal system.

Authors:  A L Gough; J E Olley
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

7.  Development of tolerance to delta9-THC in the frog.

Authors:  E L Abel
Journal:  Experientia       Date:  1973-12

8.  The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice.

Authors:  R G Pertwee
Journal:  Br J Pharmacol       Date:  1972-12       Impact factor: 8.739

9.  Interaction of cannabis and general anaesthetic agents in mice.

Authors:  G B Chesher; D M Jackson; G A Starmer
Journal:  Br J Pharmacol       Date:  1974-04       Impact factor: 8.739

10.  Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol.

Authors:  L Lemberger; R Martz; B Rodda; R Forney; H Rowe
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.